| Citric acid: An efficient and green catalyst for rapid one pot synthesis of quinoxaline derivatives at room temperature R Mahesh, AK Dhar, TS TVNV, S Thirunavukkarasu, T Devadoss Chinese Chemical Letters 22 (4), 389-392, 2011 | 51 | 2011 |
| Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress … S Bhatt, M Radhakrishnan, A Jindal, T Devadoss, AK Dhar Indian journal of pharmacology 46 (2), 191-196, 2014 | 41* | 2014 |
| Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT3 receptor antagonist in behaviour based rodent models: Evidence for … BK Gautam, A Jindal, AK Dhar, R Mahesh Pharmacology Biochemistry and Behavior 109, 91-97, 2013 | 24 | 2013 |
| Design, Synthesis, and Pharmacological Evaluation of Novel 2‐(4‐substituted piperazin‐1‐yl)1, 8 Naphthyridine 3‐Carboxylic Acids as 5‐HT3 Receptor … AK Dhar, R Mahesh, A Jindal, T Devadoss, S Bhatt Chemical Biology & Drug Design 84 (6), 721-731, 2014 | 16 | 2014 |
| Design, Synthesis and Evaluation of Antidepressant Activity of Novel 2‐Methoxy 1, 8 Naphthyridine 3‐Carboxamides as 5‐HT3 Receptor Antagonists R Mahesh, AK Dhar, A Jindal, S Bhatt Chemical Biology & Drug Design 83 (5), 583-591, 2014 | 15 | 2014 |
| Exosomes: A Novel Therapeutic paradigm for Treatment of Depression. Bhatt S, Kanoujia J, Dhar A.K, Arumugam S, K. A. Silva A Current Drug Targets, 2020 | 13* | 2020 |
| 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carboxylic acids: Novel 5-HT3 receptor antagonists with anxiolytic-like activity in rodent behavioral models R Mahesh, AK Dhar, A Jindal, S Bhatt Canadian Journal of Physiology and Pharmacology 91 (10), 848-854, 2013 | 12 | 2013 |
| Ligand‐based design, synthesis, and pharmacological evaluation of 3‐methoxyquinoxalin‐2‐carboxamides as structurally novel serotonin type‐3 receptor antagonists R Mahesh, T Devadoss, AK Dhar, SM Venkatesh, S Mundra, DK Pandey, ... Archiv der Pharmazie 345 (9), 687-694, 2012 | 12 | 2012 |
| Piperazine Analogs of Naphthyridine‐3‐carboxamides and Indole‐2‐carboxamides: Novel 5‐HT3 Receptor Antagonists with Antidepressant‐Like Activity AK Dhar, R Mahesh, A Jindal, S Bhatt Archiv der Pharmazie 348 (1), 34-45, 2015 | 11 | 2015 |
| Effective Synthesis of 1,5-Disubstituted 2,1-Benzisothiazol-3(1H)-ones. PSS Kharul R.K, Prajapati P, Thorave A, Shah H, Dhar A.K, Joshi D, Jain M ... Synthetic Communications 41 (22), 3265-3279, 2011 | 7 | 2011 |
| Antidepressant-and anxiolytic-like effect of novel 5-hydroxytryptamine3 receptor antagonist 2-[4-(3-chlorophenyl) piperazin-1-yl]-1, 8-naphthyridine-3-carboxylic acid (7e)-: An … S Bhatt, SM Bagal, S Butola, AK Dhar, R Mahesh International Journal of Nutrition, Pharmacology, Neurological Diseases 6 (2 …, 2016 | 4 | 2016 |
| Effects of current psychotropic drugs on inflammation and immune system S Bhatt, AK Dhar, MK Samanta, A Suttee Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders …, 2023 | 3 | 2023 |
| Small-molecule oligonucleotides as smart modality for antiviral therapy: a medicinal chemistry perspective SS Kar, AK Dhar, NN Palei, S Bhatt Future Medicinal Chemistry 15 (12), 1091-1110, 2023 | 1 | 2023 |
| Biosimilars in Gastric Cancer AK Dhar, SS Kar Biosimilars for Cancer Treatment: A Promising Approach, 121-142, 2024 | | 2024 |
| Biosimilars in Hepatocellular Carcinoma S Yadav, A Singh, NN Palei, AK Dhar, SC Dinda Biosimilars for Cancer Treatment: A Promising Approach, 197-209, 2024 | | 2024 |
| Drug Delivery in Biotechnology: Present and Future S Yadav, NN Palei, SC Dinda, AK Dhar Concepts in Pharmaceutical Biotechnology and Drug Development, 103-138, 2024 | | 2024 |
| Vaccines and Oncolytic Virus for the Treatment of Lung Cancer AK Dhar, NN Palei, DR Kandula Immunotherapy Against Lung Cancer: Emerging Opportunities and Challenges …, 2024 | | 2024 |
| Formulation and Evaluation of Mixed Micelles Containing Quercetin for Inhibiting Intestinal Metabolism of Atorvastatin NN Palei, J Rajangam, R Samineni, AK Dhar, A Balajı Fabad Journal of Pharmaceutical Sciences 49 (1), 51-64, 2024 | | 2024 |
| Immune system and diabetes mellitus AK Dhar, K Anitha, S Bhatt Biochemical Immunology of Diabetes and Associated Complications, 19-47, 2024 | | 2024 |
| Antimicrobial and in vitro cytotoxicity effect of green synthesized silver nanoparticles using aqueous leaf extract of Senna hirsuta NN Palei, MP Bhuvana, R Jayaraman, AK Dhar Bulletin of Pharmaceutical Sciences Assiut University 46 (2), 1185-1195, 2023 | | 2023 |
Dr. Shvetank BhattSchool of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune在 mitwpu.edu.in 的电子邮件经过验证
